Pacira BioSciences Inc (PCRX)

57.98 +0.55 (+0.96%) USD  |  NASDAQ  |  Jun 27, 11:12
More

Pacira BioSciences News

News

Headline
Wire
Time (ET)
National Safety Council and Pacira BioSciences Partner to Launch an Employee-Based Program Focused on Opioid Use and Misuse
PR Newswire
06/16 07:30
Needham Adjusts Price Target on Pacira BioSciences to $76 From $84, Reiterates Buy Rating
MT Newswires
06/15 05:36
Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $46.0 Million for May 2022
Yahoo
06/14 08:00
Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $46.0 Million for May 2022
Globe Newswire
06/14 08:00
Insider Sell: Pacira Biosciences
MT Newswires
06/09 07:06
Pacira Pharmaceuticals Stock Shows Improved Relative Price Performance; Still Shy Of Benchmark
Yahoo
06/08 14:16
Read This Before Judging Pacira BioSciences, Inc.'s (NASDAQ:PCRX) ROE
Yahoo
06/06 10:18
Why Is Pacira (PCRX) Up 2.1% Since Last Earnings Report?
Yahoo
06/03 11:32
Pacira BioSciences to Participate in Fireside Chat at the Jefferies Healthcare Conference
Yahoo
06/02 08:00
Pacira BioSciences and the National Senior Games Association Break a GUINNESS WORLD RECORDS™ Title for the Largest Game of Freeze Dance
Yahoo
05/25 10:00
Pacira BioSciences Posts Higher Exparel, Lower Iovera Sales in April
MT Newswires
05/12 09:24
Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $45.8 Million for April 2022
Yahoo
05/12 08:00
Here's Why Pacira (PCRX) is a Strong Growth Stock
Yahoo
05/10 09:45
Pacira BioSciences to Present at Two Healthcare Conferences in May
Globe Newswire
05/10 08:00
Pacira's (PCRX) Q1 Earnings Miss Estimates, Revenues Rise Y/Y
Yahoo
05/05 11:26
--RBC Capital Adjusts Pacira BioSciences' Price Target to $81 From $85, Maintains Outperform Rating
MT Newswires
05/05 09:26
Pacira BioSciences Q1 Non-GAAP EPS, Revenue Higher
MT Newswires
05/04 09:27
Pacira (PCRX) Q1 Earnings Miss Estimates
Yahoo
05/04 09:15
-- Earnings Flash (PCRX) PACIRA BIOSCIENCES Posts Q1 Revenue $158M, vs. Street Est of $155.1M
MT Newswires
05/04 08:05
Pacira BioSciences Reports First Quarter 2022 Financial Results
Yahoo
05/04 08:00
Why Pacira (PCRX) Could Beat Earnings Estimates Again
Yahoo
04/28 12:10
3 Small-Cap Medical Stocks With Big Momentum
Yahoo
04/27 11:15
Pacira to Report First Quarter 2022 Financial Results on Wednesday May 4, 2022
Globe Newswire
04/27 08:00
Pacira (PCRX) to Report Q1 Results: Wall Street Expects Earnings Growth
Yahoo
04/26 15:01
Insider Sell: Pacira BioSciences
MT Newswires
04/25 17:42
Insider Sell: Pacira Biosciences
MT Newswires
04/21 08:59
Billionaire John Paulson’s Latest Portfolio: Top 10 Stock Picks
Yahoo
04/13 17:24
Pacira BioSciences Reports Increased Preliminary Revenue for Q1
MT Newswires
04/12 08:22
Pacira BioSciences sees 32% growth in Q1 revenue: Prelim
SA Breaking News
04/12 08:19
Pacira BioSciences Reports Preliminary Revenues of $157.4 to $158.4 Million for the First Quarter of 2022
Globe Newswire
04/12 08:00
Insider Sell: Pacira BioSciences
MT Newswires
04/08 16:41
RBC Capital Adjusts Pacira BioSciences' Price Target to $85 From $83, Maintains Outperform Rating
MT Newswires
04/06 08:28
Pacira BioSciences to Participate in Fireside Chat at the 21st Annual Needham Virtual Healthcare Conference
Globe Newswire
04/05 08:00
Insider Sell: Pacira BioSciences
MT Newswires
03/23 16:58
Pacira BioSciences Logs Higher Exparel, Ioveradegree Sales in February
MT Newswires
03/15 11:11
Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $42.6 Million for February 2022
Globe Newswire
03/15 08:00
--Northland Securities Adjusts Pacira BioSciences Price Target to $67 From $61, Maintains Market Perform Rating
MT Newswires
03/01 12:41
Wedbush Trims Pacira BioSciences' Price Target to $94 From $97 on Zilretta 2022 Revenue Expectations; Outperform Rating Kept
MT Newswires
02/28 06:04
--HC Wainwright Adjusts Pacira BioSciences Price Target to $90 From $86, Maintains Buy Rating
MT Newswires
02/25 12:52
Pacira Biosciences Posts Higher Q4 Adjusted Earnings, Revenue
MT Newswires
02/24 10:13
-- Earnings Flash (PCRX) PACIRA BIOSCIENCES Posts Q4 EPS $0.99, vs. Street Est of $0.83
MT Newswires
02/24 08:01
-- Earnings Flash (PCRX) PACIRA BIOSCIENCES Posts Q4 Revenue $159.2M, vs. Street Est of $157.4M
MT Newswires
02/24 08:01
Pacira BioSciences Reports Full-Year and Fourth Quarter 2021 Financial Results
Globe Newswire
02/24 08:00
Paulson & Co. adds Cerner, KWEB to portfolio, exits Pretium, Viatris
SA Breaking News
02/15 14:14
Insider Sell: Pacira Biosciences
MT Newswires
01/21 06:17
Barclays Adjusts Pacira BioSciences Price Target to $96 From $92, Maintains Overweight Rating
MT Newswires
01/19 11:18
Big Lots, II-VI make Piper Sandler's top 20 short squeeze list: Alpha Tactics
SA Breaking News
01/08 22:15
Pacira BioSciences shares rise 3.5% after co reports prelim FY revenue growth of 26%
SA Breaking News
01/06 13:22
Pacira BioSciences Expects to Report Higher 2021 Revenue
MT Newswires
01/06 08:52
RBC Cuts Price Target on Pacira BioSciences to $83 From $86, Maintains Outperform Rating
MT Newswires
01/06 08:13
Pacira Reports Preliminary Unaudited Total Revenue for 2021 of $540.7 Million to $541.7 Million
Globe Newswire
01/06 08:00
JPMorgan Reinstates Pacira BioSciences at Overweight With $83 Price Target
MT Newswires
01/03 08:34
Pacira BioSciences to Present at the 40th Annual J.P. Morgan Healthcare Conference
Globe Newswire
01/03 08:00
--Wedbush Lifts Pacira BioSciences' Price Target to $97 From $93, Citing Zilretta Revenue Estimates; Outperform Rating Kept
MT Newswires
12/10 07:46
Pacira BioSciences Logs Higher Exparel, Iovera Sales in November
MT Newswires
12/07 08:43
Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL® and iovera° of $48.0 Million for November 2021
Globe Newswire
12/07 08:00
Pacira BioSciences to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
Globe Newswire
11/23 08:00
Pacira BioSciences Reports Higher Preliminary Net Product Sales in October Vs Year Ago
MT Newswires
11/09 14:28
Pacira Files Lawsuit Against eVenus for Patent Infringement
Globe Newswire
11/08 16:30
--Berenberg Bank Adjusts Pacira BioSciences PT to $89 From $93, Maintains Buy Rating
MT Newswires
11/05 10:39
--HC Wainwright Adjusts Pacira BioSciences PT to $86 From $80, Maintains Buy Rating
MT Newswires
11/04 14:02
Pacira BioSciences Q3 Non-GAAP EPS, Revenue Rise Year on Year
MT Newswires
11/03 09:26
-- Earnings Flash (PCRX) PACIRA BIOSCIENCES Reports Q3 Revenue $127.7M, vs. Street Est of $129.7M
MT Newswires
11/03 08:01
-- Earnings Flash (PCRX) PACIRA BIOSCIENCES Reports Q3 EPS $0.73, vs. Street Est of $0.65
MT Newswires
11/03 08:01
FLEXION THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Flexion Therapeutics, Inc. - FLXN
PR Newswire
11/02 18:35
Pacira to Report Third Quarter 2021 Financial Results on Wednesday November 3, 2021
Globe Newswire
10/27 07:30
Needham Adjusts Pacira BioSciences' Price Target to $84 from $80, Keeps Buy Rating
MT Newswires
10/18 14:37
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Flexion Therapeutics, Inc. Merger
Globe Newswire
10/12 12:00
BMO Capital Lowers Pacira BioSciences' PT to $60 from $66, Keeps Market Perform Rating
MT Newswires
10/12 08:56
HC Wainwright Adjusts Pacira BioSciences' PT to $80 from $84, Keeps Buy Rating
MT Newswires
10/12 08:14
Sector Update: Health Care Stocks Sliding in Late Monday Trading
MT Newswires
10/11 15:51
Top Midday Gainers
MT Newswires
10/11 13:24
Sector Update: Health Care Stocks Trade Lower Premarket Monday
MT Newswires
10/11 09:14
Flexion Therapeutics Agrees to Be Acquired by Pacira BioSciences; Shares Soar Pre-Bell
MT Newswires
10/11 08:11
Northland Securities Adjusts Pacira BioSciences PT to $57 From $66, Maintains Market Perform Rating
MT Newswires
10/05 10:31
Sector Update: Health Care Stocks Slide This Afternoon
MT Newswires
10/04 16:03
Sector Update: Health Care Stocks Sinking This Afternoon
MT Newswires
10/04 13:34
Pacira BioSciences Gets Notice Letter Over Generic Version of Exparel; Shares Fall
MT Newswires
10/04 09:48
Barclays Adjusts Price Target on Pacira BioSciences to $91 From $95, Maintains Overweight Rating
MT Newswires
10/01 10:34
Pacira BioSciences Says Exparel Demonstrated Safety, Tolerability in Pediatric Spinal, Cardiac Surgeries
MT Newswires
09/21 08:13
Pacira Announces Publication of Phase 3 Study of EXPAREL Infiltration in Pediatric Patients Undergoing Spinal or Cardiac Surgeries
Globe Newswire
09/21 07:30
Pacira's August Exparel Sales Rise 15% From Year Ago
MT Newswires
09/15 08:56
Pacira BioSciences Reports Preliminary Net Product Sales of $42.3 Million for August 2021
Globe Newswire
09/15 07:30
Pacira BioSciences Reports Preliminary Exparel Sales Of $40.9 Million In July
MT Newswires
08/10 12:25
Pacira BioSciences Reports Preliminary Net Product Sales of $42.1 Million for July 2021
Globe Newswire
08/10 08:00
--HC Wainwright Adjusts Price Target on Pacira BioSciences to $84 From $86, Maintains Buy Rating
MT Newswires
08/04 11:01
Pacira BioSciences to Present at the 2021 Wedbush PacGrow Healthcare Virtual Conference
Globe Newswire
08/04 08:00
Pacira BioSciences Posts Higher Q2 Earnings, Revenue
MT Newswires
08/03 11:43
-- Earnings Flash (PCRX) PACIRA BIOSCIENCES Reports Q2 EPS $0.80, vs. Street Est of $0.74
MT Newswires
08/03 08:05
-- Earnings Flash (PCRX) PACIRA BIOSCIENCES Posts Q2 Revenue $135.6M, vs. Street Est of $135M
MT Newswires
08/03 08:05
Pacira BioSciences Reports Record Revenue of $135.6 Million for the Second Quarter of 2021
Globe Newswire
08/03 08:00
Pacira Biosciences Obtains FDA Approval for Enhanced Manufacturing Process for Exparel
MT Newswires
08/02 10:13
Notable earnings before Tuesday's open
SA Breaking News
08/02 10:02
Pacira Announces FDA Approval of Enhanced EXPAREL Manufacturing Process
Globe Newswire
08/02 08:00
New Analysis Shows iovera° Plays a Critical Role in Achieving Significant Reductions in Opioid Use, Pain Scores, and Hospital Stay Following Total Knee Arthroplasty
Globe Newswire
07/29 07:30
Pacira BioSciences raised to overweight at JP Morgan; sees pullback as opportunity
SA Breaking News
07/26 08:38
JPMorgan Upgrades Pacira BioSciences to Overweight From Neutral; Price Target is $75
MT Newswires
07/26 07:19
Pacira to Report Second Quarter 2021 Financial Results on Tuesday August 3, 2021
Globe Newswire
07/20 07:30
Pacira BioSciences Reports Higher Q2 Revenue on Increased Exparel Sales
MT Newswires
07/13 08:55
Pacira BioSciences Reports Record Revenue of $135.6 Million for the Second Quarter of 2021
Globe Newswire
07/13 08:00
Biotech M&A may heat up with potential targets Horizon Therapeutics, Arrowhead Pharma, analyst says
SA Breaking News
07/11 09:00
Pacira BioSciences Signs Exparel Distribution Agreement With Eurofarma in Latin America
MT Newswires
06/22 08:52
Pacira inks EXPAREL distribution agreement with Eurofarma in Latin America
SA Breaking News
06/22 08:21
Pacira Announces EXPAREL Distribution Agreement with Eurofarma in Latin America
Globe Newswire
06/22 08:00
Pacira Biosciences' EXPAREL average daily sales more than doubles in May
SA Breaking News
06/08 12:35
Pacira BioSciences Reports Decline in Preliminary May Net Sales of Pain Management Products
MT Newswires
06/08 08:51
Pacira BioSciences Reports Preliminary Net Product Sales of $42.2 Million for May 2021
Globe Newswire
06/08 08:00
Sector Update: Health Care Stocks Slipping Ahead of Close
MT Newswires
05/26 15:53
Sector Update: Health Care Stocks Drifting Lower Again
MT Newswires
05/26 13:22
Pacira BioSciences Says Late-Stage Study Shows Potential of Exparel to be Long-Acting Lower Extremity Nerve Block
MT Newswires
05/26 09:11
Pacira Bio's Exparel fails to reach primary endpoint in late-stage STRIDE study
SA Breaking News
05/26 08:53
Pacira BioSciences Announces Top-line Results from Phase 3 STRIDE Study Evaluating EXPAREL as a Lower Extremity Nerve Block
Globe Newswire
05/26 08:00
Pacira BioSciences to Present at the 2021 Jefferies Virtual Healthcare Conference
Globe Newswire
05/25 08:00
Pacira BioSciences Secures US Notice of Allowance of Exparel Patent
MT Newswires
05/18 09:52
Pacira gets "notice of allowance" of new patent for EXPAREL
SA Breaking News
05/18 08:32
Pacira BioSciences Announces Notice of Allowance of New Patent for EXPAREL
Globe Newswire
05/18 08:00
Pacira BioSciences to Present at the 2021 RBC Capital Markets Global Healthcare Conference
Globe Newswire
05/12 08:00
Pacira BioSciences Reports Decline in April Preliminary Net Product Sales
MT Newswires
05/11 09:18
Pacira BioSciences posts a five-fold rise in EXPAREL average daily sales in April
SA Breaking News
05/11 08:22
Pacira BioSciences Reports Preliminary Net Product Sales of $44.6 Million for April 2021
Globe Newswire
05/11 08:00
--BMO Capital Adjusts Pacira BioSciences PT to $70 From $72, Maintains Market Perform Rating
MT Newswires
05/10 12:13
--Northland Capital Adjusts Pacira BioSciences PT to $66 From $75, Maintains Market Perform Rating
MT Newswires
05/05 10:57
Pacira BioSciences Posts Flat Non-GAAP Earnings, Higher Revenue in Q1
MT Newswires
05/04 09:41
Pacira BioSciences EPS misses by $0.10, beats on revenue
SA Breaking News
05/04 08:06
-- Earnings Flash (PCRX) PACIRA BIOSCIENCES Reports Q1 EPS $0.56, vs. Street Est of $0.63
MT Newswires
05/04 08:01
-- Earnings Flash (PCRX) PACIRA BIOSCIENCES Reports Q1 Revenue $119M, vs. Street Est of $118.9M
MT Newswires
05/04 08:01
Pacira BioSciences Reports First Quarter 2021 Financial Results and Business Update
Globe Newswire
05/04 08:00
Pacira BioSciences Q1 2021 Earnings Preview
SA Breaking News
05/03 13:54
Notable earnings before Tuesday's open
SA Breaking News
05/03 13:04
Pacira to Report First Quarter 2021 Financial Results on Tuesday May 4, 2021
Globe Newswire
04/21 07:30
Pacira BioSciences Makes $3 Million Investment in Spine BioPharma
MT Newswires
04/20 08:12
Pacira Biosciences invests in Spine BioPharma
SA Breaking News
04/20 07:50
Spine BioPharma Announces Investment by Pacira Biosciences
PR Newswire
04/20 07:30
Pacira BioSciences Announces Investment in Spine BioPharma
Globe Newswire
04/20 07:30
Pacira BioSciences Sues to Have Negative Medical Journal Articles Retracted
MT Newswires
04/14 16:23
Pacira BioSciences Seeks Court Injunction to Protect Clinical Integrity of EXPAREL in the Face of Scientifically Flawed and Misleading Information Published in Anesthesiology
Globe Newswire
04/14 16:00
Analyst Actions: Berenberg Initiates Pacira BioSciences at Buy Rating With $93 Price Target
MT Newswires
04/09 10:03
Pacira Reports Preliminary Net Product Sales of $118.7 Million for the First Quarter of 2021
Globe Newswire
04/07 08:00
Analyst Actions: Wedbush Raises Pacira BioSciences' PT to $93 from $89 After Securing FDA Approval For EXPAREL in Pediatric Patients, Keeps Outperform Rating
MT Newswires
03/25 09:49
Ionis Pharma gets positive views from analysts; slide extends to developers on HT
SA Breaking News
03/23 15:20
Pacira BioSciences Secures FDA's Approval For Supplemental New Drug Application For Exparel in Pediatric Patients
MT Newswires
03/23 04:59
FDA OKs expanded use of Pacira's Exparel in pediatric patients
SA Breaking News
03/23 04:12
Pacira Announces FDA Approval of Supplemental New Drug Application for EXPAREL® (bupivacaine liposome injectable suspension) in Pediatric Patients
Globe Newswire
03/22 18:42
Seeking Alpha Catalyst Watch
SA Breaking News
03/19 15:30
Pacira BioSciences Posts Sequential Rise in February Net Product Sales
MT Newswires
03/09 08:47
Pacira BioSciences Reports Preliminary Net Product Sales of $36.2 Million for February 2021
Globe Newswire
03/09 08:00
Pacira BioSciences to Present at the 2021 Barclays Global Healthcare Conference
Globe Newswire
03/03 07:30
--Analyst Actions: HC Wainwright & Co. Adjusts Price Target on Pacira BioSciences to $86 From $70, Maintains Buy Rating
MT Newswires
03/01 10:21
--Analyst Actions: Barclays Adjusts Price Target on Pacira BioSciences to $94 From $79, Reiterates Overweight Rating
MT Newswires
02/26 11:25
--Analyst Actions: RBC Capital Adjusts Price Target on Pacira BioSciences to $86 From $78, Maintains Outperform Rating
MT Newswires
02/26 08:46
--Analyst Actions: Wedbush Adjusts Price Target on Pacira BioSciences to $89 From $83, Keeps Outperform Rating
MT Newswires
02/26 08:42
Pacira BioSciences Earnings, Revenue Rise in Q4
MT Newswires
02/25 08:22
Pacira BioSciences EPS beats by $0.06, revenue in-line
SA Breaking News
02/25 08:03
-- Earnings Flash (PCRX) PACIRA BIOSCIENCES Reports Q4 EPS $0.87, vs. Street Est of $0.81
MT Newswires
02/25 08:01
-- Earnings Flash (PCRX) PACIRA BIOSCIENCES Posts Q4 Revenue $131M, vs. Street Est of $130.9M
MT Newswires
02/25 08:01
Pacira BioSciences Reports Full-Year and Fourth Quarter 2020 Financial Results
Globe Newswire
02/25 08:00
Notable earnings before Thursday's open
SA Breaking News
02/24 12:49
Pacira BioSciences Q4 2020 Earnings Preview
SA Breaking News
02/24 11:49
Pacira to Report 2020 Financial Results on Thursday February 25, 2021
Globe Newswire
02/18 07:30
--Analyst Actions: Northland Downgrades Pacira BioSciences to Market Perform From Outperform, Adjusts Price Target to $75 From $72
MT Newswires
02/11 11:18
Pacira BioSciences Expects $36 Million in Product Sales in January
MT Newswires
02/10 09:38
Pacira BioSciences reports January prelim net product sales
SA Breaking News
02/10 07:33
Pacira BioSciences Reports Preliminary Net Product Sales of $36.0 Million for January 2021
Globe Newswire
02/10 07:00
Pacira Biosciences to Invest up to EUR6 Million in German Gene Therapy Firm GeneQuine Biotherapeutics
MT Newswires
01/26 10:39
Pacira BioSciences Announces Equity Investment in GeneQuine Biotherapeutics
Globe Newswire
01/26 08:00
Pacira BioSciences sheds 7% after SVB Leerink downgrade
SA Breaking News
01/21 12:17
Analyst Actions: SVB Leerink Downgrades Pacira BioSciences to Market Perform From Outperform; Price Target is $75
MT Newswires
01/21 07:56
Analyst Actions: Needham Adjusts Price Target on Pacira BioSciences to $76 From $67, Keeps Buy Rating
MT Newswires
01/08 11:21
Analyst Actions: RBC Capital Adjusts Pacira BioSciences' Price Target to $78 From $70, Maintains Outperform Rating
MT Newswires
01/08 07:59
Pacira BioSciences reports subdued growth for 2020
SA Breaking News
01/07 08:18
Pacira BioSciences Reports 2020 Revenue Just Ahead of Street Estimate
MT Newswires
01/07 08:04
Pacira Reports Record Revenue for 2020 of $429.6 Million
Globe Newswire
01/07 07:30
AbbVie, Viatris, Pacira 'Positioned Offensively' for Post-COVID Upside; Small Cap Specialty Pharma Sees Recovery, RBC Says
MT Newswires
01/06 11:12
Pacira BioSciences to Present at the 39th Annual J.P. Morgan Healthcare Conference
Globe Newswire
01/06 07:30
Pacira BioSciences Reports Preliminary Net Sales for Pain Management Products Exparel and Iovera
MT Newswires
12/09 14:29
Analyst Actions: Needham Adjusts Price Target on Pacira BioSciences to $67 From $68, Reiterates Buy Rating
MT Newswires
12/09 11:42
Pacira BioSciences' preliminary net product November sales of $38.9M
SA Breaking News
12/09 07:39
Pacira BioSciences Reports Preliminary Net Product Sales of $38.9 Million for November 2020
Globe Newswire
12/09 07:30
Pacira BioSciences to Present at the 2020 Piper Sandler 32nd Annual Virtual Healthcare Conference
Globe Newswire
11/24 07:30
Pacira Obtains European Approval for Postsurgical Pain Therapeutic
MT Newswires
11/18 08:29
Pacira's postsurgical pain med Ok'd in Europe
SA Breaking News
11/18 08:08
Pacira Receives European Commission Approval for EXPAREL® (bupivacaine liposome injectable suspension) for the Treatment of Postsurgical Pain
Globe Newswire
11/18 07:30
Pacira BioSciences Reports Sales of $41.7 Million in October
MT Newswires
11/11 09:06
Pacira BioSciences reports October net product sales
SA Breaking News
11/11 08:04
Pacira BioSciences Reports Preliminary Net Product Sales of $41.7 Million for October 2020
Globe Newswire
11/11 08:00
Pacira BioSciences to Present at the 2020 Jefferies Virtual London Healthcare Conference
Globe Newswire
11/10 07:30
--Analyst Actions: Wedbush Adjusts Pacira BioSciences' Price Target to $83 From $85, Keeps Outperform Rating
MT Newswires
11/02 06:23
-- Earnings Flash (PCRX) PACIRA BIOSCIENCES Reports Q3 Revenue $117.5M, vs. Street Est of $115.9M
MT Newswires
10/29 08:04
-- Earnings Flash (PCRX) PACIRA BIOSCIENCES Posts Q3 EPS $0.70, vs. Street Est of $0.65
MT Newswires
10/29 08:04
Pacira BioSciences EPS beats by $0.03, beats on revenue
SA Breaking News
10/29 08:03
Pacira BioSciences Reports Third Quarter 2020 Financial Results and Business Update
Globe Newswire
10/29 08:00
Pacira BioSciences Q3 2020 Earnings Preview
SA Breaking News
10/28 13:50
Notable earnings before Thursday's open
SA Breaking News
10/28 11:33
Pacira Launches State-of-the-Art Training Center Dedicated to Advancing Best Practice Regional Approaches to Manage Acute Pain
Globe Newswire
10/21 07:30
Pacira to Report Third Quarter 2020 Financial Results on Thursday October 29, 2020
Globe Newswire
10/20 07:30
Pacira BioSciences Says Preliminary Net Product Sales $116.9 Million in Q3
MT Newswires
10/07 09:30
Pacira Bio sees Exparel sales of $113.7M for Q3 2020
SA Breaking News
10/07 09:11
Pacira BioSciences Reports Preliminary Net Product Sales of $116.9 Million for the Third Quarter of 2020
Globe Newswire
10/07 08:00
Analyst Actions: Northland Upgrades Pacira BioSciences to Outperform From Market Perform, Adjusts Price Target to $67 From $58
MT Newswires
09/21 09:42
Pacira BioSciences Receives Positive European Medicines Agency Opinion for Exparel to Treat Postsurgical Pain
MT Newswires
09/18 09:45
Pacira Receives Positive CHMP Opinion for EXPAREL® (bupivacaine liposome injectable suspension) for the Treatment of Postsurgical Pain
Globe Newswire
09/18 08:07
European advisory group backs Pacira pain med Exparel
SA Breaking News
09/18 07:57
Pacira BioSciences, IPG Sign Collaboration Deal to Reduce Postsurgical Opioid Prescribing, Surgical Procedure Costs
MT Newswires
09/15 12:13
IPG and Pacira BioSciences Announce Collaboration to Reduce Postsurgical Opioid Prescribing and Surgical Procedure Costs
Globe Newswire
09/15 07:30
Pacira BioSciences to Present at the 2020 H.C. Wainwright 22nd Annual Global Investment Conference
Globe Newswire
09/11 07:30
--Analyst Actions: Needham Adjusts Price Target on Pacira BioSciences to $68 From $64, Maintains Buy
MT Newswires
09/09 12:07
Pacira BioSciences Expects Analgesic Sales of $36.9 Million in August
MT Newswires
09/09 09:20
Pacira BioSciences Reports Preliminary Net Product Sales of $36.9 Million for August 2020
Globe Newswire
09/09 08:00
--Analyst Actions: RBC Capital Lifts Price Target on Pacira BioSciences to $65 From $63, Maintains Outperform Rating
MT Newswires
08/07 08:43
-- Earnings Flash (PCRX) PACIRA BIOSCIENCES Posts Q2 EPS $0.12, vs. Street Est of $0.09
MT Newswires
08/06 08:04
Pacira BioSciences EPS beats by $0.03, revenue in-line
SA Breaking News
08/06 08:04
-- Earnings Flash (PCRX) PACIRA BIOSCIENCES Posts Q2 Revenue $75.5M, vs. Street Est of $75.6M
MT Newswires
08/06 08:04
Pacira BioSciences Reports Second Quarter 2020 Financial Results and Business Update
Globe Newswire
08/06 08:00
Pacira BioSciences to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
Globe Newswire
08/05 16:05
Notable earnings before Thursday's open
SA Breaking News
08/05 13:25
Pacira BioSciences Q2 2020 Earnings Preview
SA Breaking News
08/05 12:49
Pacira Announces Publication of Phase 4 Study of EXPAREL in Cesarean Section Procedures in Anesthesia & Analgesia
Globe Newswire
08/05 07:30
FDA accepts Pacira's supplement application for expanded use of EXPAREL for post operative pain
SA Breaking News
08/04 09:54
Pacira BioSciences Announces FDA Acceptance of sNDA for EXPAREL Use in Pediatric Patients
Globe Newswire
08/04 07:30
--Analyst Actions: RBC Capital Lifts Pacira BioSciences' Price Target to $63 From $62, Maintains Outperform Rating
MT Newswires
07/31 09:03
Pacira to Report Second Quarter 2020 Financial Results on Thursday August 6, 2020
Globe Newswire
07/30 07:30
Pacira Biosciences to Pay $3.5 Million to Settle Government Claims Related to Exparel Painkiller
MT Newswires
07/29 06:56
Pacira BioSciences Announces Settlement of Government Investigation
Globe Newswire
07/28 17:03
Analyst Actions: HC Wainwright Lifts Price Target on Pacira BioSciences to $68 From $63, Reiterates Buy Rating
MT Newswires
07/13 14:04
Analyst Actions: Jefferies Raises Price Target on Pacira BioSciences to $69 From $53, Maintains Buy Rating
MT Newswires
07/10 11:10
Pacira Bio prices $350M convertible debt offering
SA Breaking News
07/08 05:00
Pacira BioSciences Prices Upsized Private Sale of Convertible Senior Notes Due 2025
MT Newswires
07/08 04:37
Pacira BioSciences, Inc. Announces Pricing of $350.0 Million Aggregate Principal Amount of 0.750% Convertible Senior Notes due 2025
Globe Newswire
07/07 19:51
OTIC, PCRX, COHN and TRIB among after-hours movers
SA Breaking News
07/06 17:31
Pacira BioSciences under pressure on preliminary Q2 results
SA Breaking News
07/06 17:29
Pacira BioSciences Q2 Preliminary Revenue Ahead of Estimates, Plans $300 Million Notes Offering - Stock Down 4% After-Hours
MT Newswires
07/06 16:17
Pacira BioSciences, Inc. Announces Proposed Offering of $300.0 Million Aggregate Principal Amount of Convertible Senior Notes
Globe Newswire
07/06 16:02
Pacira BioSciences Reports Preliminary Total Revenue of $75.5 Million for Second Quarter of 2020
Globe Newswire
07/06 16:01
Analyst Actions: Needham Lifts Pacira BioSciences' Price Target to $64 From $52, Reiterates Buy Rating
MT Newswires
07/06 08:57
Pacira BioSciences to Terminate Exparel Co-Promotion Deal With DePuy Synthes
MT Newswires
07/02 08:03
Pacira BioSciences Announces Conclusion of EXPAREL Agreement with DePuy Synthes
Globe Newswire
07/02 07:30
Analyst Actions: RBC Capital Lifts Pacira BioSciences' Price Target to $62 From $56, Maintains Outperform Rating
MT Newswires
07/01 07:40
Analyst Actions: Northland Securities Lifts Pacira BioSciences' Price Target to $54 From $50, Keeps at Market Perform
MT Newswires
06/30 12:14
Healthcare - Top 5 Gainers / Losers
SA Breaking News
06/29 11:06
Pacira BioSciences surges after Heron receives CRL
SA Breaking News
06/29 09:56
Pacira BioSciences to Present at the 2020 BMO Prescriptions for Success Healthcare Conference
Globe Newswire
06/16 07:30
Analyst Actions: Guggenheim Initiates Pacira BioSciences at Neutral
MT Newswires
05/27 09:54
Pacira BioSciences to Present at the 2020 Jefferies Virtual Healthcare Conference
Globe Newswire
05/27 07:30
J.P. Morgan picks spec pharma favorites after earnings
SA Breaking News
05/19 16:07
Sandell buys Taubman, exits Pacira BioSciences
SA Breaking News
05/15 10:36
Pacira BioSciences to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference
Globe Newswire
05/13 07:30
Analyst Actions: SVB Leerink Lifts Pacira BioSciences' Price Target to $45 From $44, Keeps Outperform Rating
MT Newswires
05/08 10:23
Pacira BioSciences Posts Higher Q1 Results, Withdraws 2020 Guidance Amid COVID-19 Pandemic
MT Newswires
05/07 08:28
Pacira Pharmaceuticals EPS beats by $0.23, beats on revenue
SA Breaking News
05/07 08:05
Pacira BioSciences Reports First Quarter 2020 Financial Results and Business Update
Globe Newswire
05/07 08:00